W. Klaus

1.8k total citations
122 papers, 1.4k citations indexed

About

W. Klaus is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, W. Klaus has authored 122 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 40 papers in Molecular Biology and 19 papers in Physiology. Recurrent topics in W. Klaus's work include Cardiac electrophysiology and arrhythmias (30 papers), Ion channel regulation and function (18 papers) and Nitric Oxide and Endothelin Effects (14 papers). W. Klaus is often cited by papers focused on Cardiac electrophysiology and arrhythmias (30 papers), Ion channel regulation and function (18 papers) and Nitric Oxide and Endothelin Effects (14 papers). W. Klaus collaborates with scholars based in Germany, Czechia and China. W. Klaus's co-authors include Uwe Fricke, A.F.E. Rump, Stefan Dhein, R. Rösen, G. Kuschinsky, Andreas Müller, H. L�llmann, R. Krebs, E. Muscholl and Deniz Açar and has published in prestigious journals such as Circulation, European Heart Journal and British Journal of Pharmacology.

In The Last Decade

W. Klaus

118 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Klaus Germany 21 632 567 233 159 158 122 1.4k
S Harigaya United States 16 442 0.7× 696 1.2× 138 0.6× 127 0.8× 91 0.6× 49 1.2k
A. Farah United States 20 620 1.0× 565 1.0× 182 0.8× 129 0.8× 88 0.6× 85 1.5k
R. Xhonneux Belgium 19 817 1.3× 593 1.0× 321 1.4× 287 1.8× 213 1.3× 50 1.7k
R. G. Shanks United Kingdom 19 481 0.8× 414 0.7× 156 0.7× 163 1.0× 79 0.5× 47 1.5k
Adawia A. Alousi United States 21 1.1k 1.7× 703 1.2× 314 1.3× 188 1.2× 132 0.8× 30 2.0k
Wolfgang Klaus Germany 20 493 0.8× 494 0.9× 253 1.1× 123 0.8× 89 0.6× 47 1.2k
Gareth W. John France 21 309 0.5× 522 0.9× 185 0.8× 270 1.7× 129 0.8× 65 1.1k
Kathryn A. Lysko United States 8 310 0.5× 343 0.6× 244 1.0× 92 0.6× 77 0.5× 8 889
Sisto Luciani Italy 23 248 0.4× 838 1.5× 208 0.9× 200 1.3× 58 0.4× 77 1.3k
Inge‐Britt Lindén Finland 15 374 0.6× 261 0.5× 119 0.5× 175 1.1× 54 0.3× 35 1.2k

Countries citing papers authored by W. Klaus

Since Specialization
Citations

This map shows the geographic impact of W. Klaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Klaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Klaus more than expected).

Fields of papers citing papers by W. Klaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Klaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Klaus. The network helps show where W. Klaus may publish in the future.

Co-authorship network of co-authors of W. Klaus

This figure shows the co-authorship network connecting the top 25 collaborators of W. Klaus. A scholar is included among the top collaborators of W. Klaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Klaus. W. Klaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rump, A.F.E., M. Theisohn, Roman Fischbach, et al.. (2002). Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. European Journal of Clinical Pharmacology. 58(7). 459–465. 16 indexed citations
2.
Rump, A.F.E., Jörg Michael Schierholz, M. Theisohn, et al.. (1999). Pseudocholinesterase-Activity Reduction during Cardiopulmonary Bypass. General Pharmacology The Vascular System. 32(1). 65–69. 5 indexed citations
3.
Rump, A.F.E., M. Theisohn, Jörg Michael Schierholz, et al.. (1996). Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases. General Pharmacology The Vascular System. 27(4). 669–671. 5 indexed citations
4.
Müller, Andreas, et al.. (1996). Crataegus extract prolongs action potential duration in guinea-pig papillary muscle. Phytomedicine. 3(3). 257–261. 17 indexed citations
5.
Rump, A.F.E. & W. Klaus. (1995). Functional Effects of Adrenochrome in Isolated Rabbit Heart. Pharmacology & Toxicology. 77(2). 102–105. 1 indexed citations
6.
Dhein, Stefan, M. Schott, Eric Gottwald, & W. Klaus. (1995). Electrocardiological profile and proarrhythmic effects of quinidine, verapamil and their combination: a mapping study. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(1). 94–101. 1 indexed citations
7.
Rump, A.F.E., et al.. (1994). Comparative effects of the Dihydropyridine-type calcium-agonists (−)-S-Bay K 8644, (±)-Bay-W 5035 and (±)-Bay-T 5006 on human platelet aggregability. General Pharmacology The Vascular System. 25(3). 447–450. 5 indexed citations
8.
Rump, A.F.E., Deniz Açar, R. Rösen, & W. Klaus. (1994). Functional and Antiischaemic Effects of the Phosphodiesterase Inhibitor Levosimendan in Isolated Rabbit Hearts. Pharmacology & Toxicology. 74(6). 244–248. 41 indexed citations
9.
Rump, A.F.E., Deniz Açar, & W. Klaus. (1994). A quantitative comparison of functional and anti‐ischaemic effects of the phosphodiesterase‐inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. British Journal of Pharmacology. 112(3). 757–762. 37 indexed citations
10.
11.
Rump, A.F.E., Deniz Açar, Arno Cordes, et al.. (1994). Functional and antiischemic effects of luteolin-7-glucoside in isolated rabbit hearts. General Pharmacology The Vascular System. 25(6). 1137–1142. 19 indexed citations
12.
Rump, A.F.E., et al.. (1993). Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts.. PubMed. 43(12). 1262–6. 11 indexed citations
13.
Rump, A.F.E., et al.. (1993). Beneficial effect of amrinone on the size of acute regional ischemia in isolated rabbit hearts. Journal of Cardiothoracic and Vascular Anesthesia. 7(5). 573–578. 8 indexed citations
14.
Dhein, Stefan, Robert D. Gerwin, M. Schott, et al.. (1993). Propranolol unmasks class III like electrophysiological properties of norepinephrine. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(6). 643–649. 2 indexed citations
15.
Rump, A.F.E., et al.. (1993). Deleterious effect of exogenous angiotensin-I on the extent of regional ischaemia and its inhibition by captopril. European Heart Journal. 14(1). 106–112. 16 indexed citations
16.
Rump, A.F.E., et al.. (1993). Influence of (−)-S-Bay K 8644, (±)-Bay W 5035 and (±)-Bay T 5006 on hemodynamics and FITC-Dextran 3 elution kinetics in isolated rat hearts. General Pharmacology The Vascular System. 24(3). 631–636. 3 indexed citations
17.
Dhein, Stefan, Robert D. Gerwin, Andreas Borowski, et al.. (1991). Endothelial Function and Contractility of Human Vena Saphena Magna Prepared for Aortocoronary Bypass Grafting. The Thoracic and Cardiovascular Surgeon. 39(2). 66–69. 12 indexed citations
18.
Dhein, Stefan, Andreas Müller, & W. Klaus. (1990). Nifedipine antagonizes ouabain-induced ST-segment changes and derangement of epicardial activation pattern in isolated rabbit hearts. International Journal of Cardiology. 29(2). 163–172. 8 indexed citations
19.
Dhein, Stefan, Andreas Müller, & W. Klaus. (1989). The potential of epicardial activation mapping in isolated hearts for the assessment of arrhythmogenic and antiarrhythmic drug activity. Journal of Pharmacological Methods. 22(3). 197–206. 14 indexed citations
20.
Klaus, W., et al.. (1979). Antagonistic effect of triamterene to ouabain toxicity.. PubMed. 29(4). 623–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Harigaya Breakdown of academic impact, for papers by A. Farah Breakdown of academic impact, for papers by R. Xhonneux Breakdown of academic impact, for papers by R. G. Shanks Breakdown of academic impact, for papers by Adawia A. Alousi Breakdown of academic impact, for papers by Wolfgang Klaus Breakdown of academic impact, for papers by Gareth W. John Breakdown of academic impact, for papers by Kathryn A. Lysko Breakdown of academic impact, for papers by Sisto Luciani Breakdown of academic impact, for papers by Inge‐Britt Lindén
Rankless by CCL
2026